Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
作者信息
O'Moráin N, Stack R, Doherty J, Tosetto M, Garcia Leon A, Mallon P, Doherty G
机构信息
Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland.
Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland.
出版信息
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.016. Epub 2022 Jun 26.
Abstract
摘要
相似文献
1
Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.06.016. Epub 2022 Jun 26.
2
COVID-19 and intestinal inflammation: Role of fecal calprotectin.
Dig Liver Dis. 2020 Nov;52(11):1231-1233. doi: 10.1016/j.dld.2020.09.015. Epub 2020 Sep 22.
3
Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients.
J Infect. 2022 Feb;84(2):e27-e29. doi: 10.1016/j.jinf.2021.11.017. Epub 2021 Nov 27.
4
A meta-analysis of the association between calprotectin and the severity of COVID-19.
J Infect. 2022 Mar;84(3):e31-e33. doi: 10.1016/j.jinf.2022.01.022. Epub 2022 Jan 21.
5
Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.
Inflamm Res. 2021 Jun;70(6):687-694. doi: 10.1007/s00011-021-01465-y. Epub 2021 May 6.
6
Assessment of the predictive value of plasma calprotectin in the evolution of SARS-Cov-2 primo-infection.
Infect Dis Now. 2024 Mar;54(2):104860. doi: 10.1016/j.idnow.2024.104860. Epub 2024 Feb 1.
7
Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.
J Clin Lab Anal. 2021 Nov;35(11):e24004. doi: 10.1002/jcla.24004. Epub 2021 Oct 5.
8
Calprotectin: The Link Between Acute Lung Injury and Gastrointestinal Injury in Covid-19: Ban or Boon.
Curr Protein Pept Sci. 2022;23(5):310-320. doi: 10.2174/1389203723666220610124303.
9
[Faecal calprotectin is a useful biomarker for intestinal inflammation].
Ugeskr Laeger. 2014 Sep 8;176(37).
10
Fecal calprotectin levels in COVID-19: Lessons from a systematic review on its use in inflammatory bowel disease during the pandemic.
Dig Liver Dis. 2021 Mar;53(3):295-297. doi: 10.1016/j.dld.2020.10.021. Epub 2020 Oct 19.
引用本文的文献
1
Alterations in gut immunological barrier in SARS-CoV-2 infection and their prognostic potential.
Front Immunol. 2023 Mar 15;14:1129190. doi: 10.3389/fimmu.2023.1129190. eCollection 2023.
2
Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19.
World J Gastroenterol. 2022 Dec 28;28(48):6811-6826. doi: 10.3748/wjg.v28.i48.6811.
Zotero 插件